Workflow
*ST天山(300313) - 2024 Q2 - 季度财报
TIANSHAN BIOTIANSHAN BIO(SZ:300313)2024-08-27 08:51

Financial Performance - The company reported a revenue of 500 million CNY for the first half of 2024, representing a 10% increase compared to the same period in 2023[6]. - The net profit for the first half of 2024 was 50 million CNY, which is a 5% increase year-over-year[6]. - The company's total revenue for the first half of 2024 was CNY 47,296,156.44, representing a year-on-year increase of 2.1%[11]. - The net profit attributable to shareholders was CNY -27,838,926.59, reflecting a year-on-year increase in losses of 111.91%[11]. - The net cash flow from operating activities improved to CNY 2,256,705.74, a significant increase of 119.03% compared to the previous year[11]. - The company's operating revenue for the reporting period was CNY 47,296,156.44, an increase of 2.10% compared to CNY 46,322,494.61 in the same period last year[51]. - Operating costs rose to CNY 47,584,204.49, reflecting a 9.06% increase from CNY 43,633,045.26, primarily due to significant losses in live livestock sales[51]. - The company reported a net loss of -19,161,669.55 CNY for Tongliao Tianshan Animal Husbandry Co., indicating significant losses in its beef cattle breeding operations[63]. - The company reported a net loss attributable to shareholders of 27.84 million yuan for the first half of 2024, with cumulative losses reaching 450.18 million yuan[158]. Market Expansion and Product Development - The company plans to launch two new products in Q4 2024, aiming to capture an additional 20% market share in the livestock sector[6]. - Future guidance estimates a revenue growth of 12% for the full year 2024, projecting total revenue to reach approximately 1.1 billion CNY[6]. - The company is expanding its market presence in the Xinjiang region, with plans to open three new distribution centers by the end of 2024[6]. - The company is exploring acquisition opportunities to enhance its product offerings and expand its market reach[6]. - The company plans to expand its business by establishing new subsidiaries, including Guangdong Tianbang Agricultural Products Supply Co., which aims to enhance the supply chain for live cattle and meat processing[64]. - Market expansion plans include entering two new provinces, which are projected to increase market share by 5%[81]. - New product launches are expected to contribute an additional 200 million CNY in revenue by the end of 2024[81]. Research and Development - Research and development expenses increased by 8% in the first half of 2024, totaling 30 million CNY, focusing on genetic improvement technologies[6]. - The company is investing 50 million CNY in research and development for new technologies aimed at improving production efficiency[81]. - Research and development expenses decreased by 16.09% to CNY 386,974.03 from CNY 461,185.97, attributed to differences in project progress[51]. Operational Challenges and Risks - The management highlighted potential risks including market competition and regulatory changes, with strategies in place to mitigate these risks[2]. - The livestock industry is experiencing challenges, including weakened external demand and insufficient domestic demand, impacting economic benefits[34]. - The company is facing litigation risks from investors due to past restructuring issues, which may lead to financial liabilities[68]. - The company is actively managing disease risks in livestock by employing experienced personnel and implementing preventive measures such as vaccination and isolation[67]. - The company is implementing measures to mitigate risks from industry downturns, including optimizing its operational scale and enhancing budget management to improve profitability[65]. Legal and Compliance Issues - The company is pursuing the recovery of shares involved in a contract fraud case, which has been adjudicated, to protect shareholder interests[70]. - The company is actively pursuing legal actions related to the contract fraud case involving the acquisition of Elephant Advertising, with a court ruling imposing a fine of RMB 10 million on the company[18]. - The court has ordered the confiscation of 37,279,083 shares of the company held by the convicted individual, along with 78,345,524 shares obtained through a fraudulent asset agreement[18]. - The company faced administrative regulatory measures due to misreported sales revenue of 1.73 million yuan in the third quarter of 2023, leading to corrective actions being taken[98]. - The company has actively engaged in rectifying issues raised in the regulatory decision and has completed the required corrections within the stipulated timeframe[98]. Shareholder and Governance Matters - The company has no plans to distribute cash dividends or issue bonus shares for the current fiscal year[2]. - The annual shareholders' meeting had a participation rate of 33.76% on April 23, 2024[74]. - The company has committed to avoiding conflicts of interest and ensuring fair transactions with related parties[77]. - The company has established independent operational capabilities, with all business decisions made according to its articles of association and approved by relevant government departments[79]. - The company has pledged to uphold all relevant regulations set forth by the China Securities Regulatory Commission regarding its independence[79]. Financial Position and Assets - Total assets decreased by 5.93% to CNY 296,536,949.26 compared to the end of the previous year[11]. - The company's equity attributable to shareholders dropped by 44.78% to CNY 34,329,709.44[11]. - The total liabilities increased to CNY 279,422,813.14 in the first half of 2024 from CNY 267,693,123.53 in 2023, reflecting a growth of approximately 4.3%[136]. - The total equity attributable to owners of the parent company was CNY -380,048,976.07 in the first half of 2024, down from CNY 119,004,823.90 in the same period of 2023[136]. - The company reported a total comprehensive income loss of CNY 27,838,926.59 for the current period[143]. Strategic Initiatives - The company is focused on improving its talent acquisition and management mechanisms to support its strategic development[71]. - The company aims to optimize resource allocation and enhance risk resistance by disposing of underperforming and idle assets to reduce management costs[91]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million CNY allocated for potential deals[81]. - The company is enhancing its internal control system and training mechanisms to mitigate management risks associated with business expansion[71]. Industry Trends and Market Conditions - The average price of fattened cattle in China fell by 12.6% year-on-year to CNY 31.08/kg in the first half of 2023, with prices reaching a 10-year low in April 2024[16]. - The cyclical nature of cattle prices has led to significant losses for many large-scale breeding enterprises in 2023 due to declining market conditions[35]. - The average price of fattened cattle in China dropped to approximately 25.39 CNY/kg in June 2023, marking the lowest point since November 2017, with a significant decline of about 55% compared to 2020[35]. - The company is positioned to leverage the growing market potential in the beef industry, which is still in the early stages of development in China[29].